comparemela.com

Latest Breaking News On - Director timothy - Page 5 : comparemela.com

Home Federal Bancorp, Inc. of Louisiana (NASDAQ:HFBL) Short Interest Up 100.0% in May

Home Federal Bancorp, Inc. of Louisiana (NASDAQ:HFBL – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 4,400 shares, a growth of 100.0% from the April 30th total of 2,200 shares. Currently, 0.2% of the shares of […]

Louisiana
United-states
Timothyw-wilhite
Glenw-brown
Insider-activity-at-home-federal-bancorp-inc
Level-four-advisory-services
Institutional-trading-of-home-federal-bancorp-inc
Home-federal-bancorp-inc-of-louisiana
News-ratings-for-home-federal-bancorp-inc
Securities-exchange-commission
Exchange-commission

Insulet Co. (NASDAQ:PODD) Director Timothy J. Scannell Sells 3,300 Shares

Insulet Co. (NASDAQ:PODD – Get Free Report) Director Timothy J. Scannell sold 3,300 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $180.90, for a total transaction of $596,970.00. Following the sale, the director now owns 42,586 shares in the company, valued […]

New-york
United-states
Timothyj-scannell
Lindbrook-capital
Portfolio-review-corp
Insulet-corporation
Wolfe-research
Linden-thomas-advisory-services
Barclays
Fourthought-financial-partners
Jpmorgan-chase-co

Veeva Systems Inc. (NYSE:VEEV) Stake Boosted by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. grew its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 56.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 424,774 shares of the technology company’s stock after purchasing an additional 152,501 shares during […]

United-states
Canada
Alan-mateo
Veeva-opendata
Robertw-baird
Veeva-crossix
Timothys-cabral
Exchange-commission
Quantum-capital-management
Citigroup
Royal-bank
Jefferies-financial-group

HC Wainwright Reiterates "Buy" Rating for Cartesian Therapeutics (NASDAQ:RNAC)

HC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Thursday, Benzinga reports. HC Wainwright currently has a $54.00 target price on the stock. A number of other research firms have also issued reports on RNAC. Needham & Company LLC reaffirmed a buy rating and […]

United-states
American
Leerink-partnrs
Hall-laurie
Timothya-springer
Securities-exchange-commission
American-international-group-inc
Delphi-financial-group-inc
Needham-company
Cartesian-therapeutics-inc
Sg-americas-securities
Cartesian-therapeutics

Cartesian Therapeutics' (RNAC) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Thursday, Benzinga reports. They currently have a $54.00 price target on the stock. Other equities research analysts have also recently issued reports about the stock. Needham & Company LLC reiterated a buy rating and set […]

United-states
American
Timothya-springer
Hall-laurie
Leerink-partnrs
Cartesian-therapeutics-inc
Sg-americas-securities
American-international-group-inc
Delphi-financial-group-inc
Needham-company
Cartesian-therapeutics
Free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.